Actelion (XSWX:ATLNE) Buildings And Improvements : CHF0 Mil (As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Buildings And Improvements?

Actelion's quarterly buildings and improvements increased from Sep. 2016 (CHF0 Mil) to Dec. 2016 (CHF328 Mil) but then declined from Dec. 2016 (CHF328 Mil) to Mar. 2017 (CHF0 Mil).

Actelion's annual buildings and improvements increased from Dec. 2014 (CHF326 Mil) to Dec. 2015 (CHF327 Mil) and increased from Dec. 2015 (CHF327 Mil) to Dec. 2016 (CHF328 Mil).

Actelion Buildings And Improvements Historical Data

The historical data trend for Actelion's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Buildings And Improvements Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Buildings And Improvements

Get a 7-Day Free Trial

218.75

318.82

325.64

327.22

328.05

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Buildings And Improvements	Get a 7-Day Free Trial															-	-	-	328.05	-

Actelion Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Actelion (XSWX:ATLNE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLNE) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (XSWX:ATLNE) Headlines

No Headlines